PTC Therapeutics, Inc.
NASDAQ:PTCT
42.96 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||
| Net Income
| -626.604 | -559.017 | -523.901 | -438.16 | -251.576 | -128.081 | -79 | -142.11 | -170.447 | -93.753 | -51.574 | -26.235 | 30.905 |
| Depreciation & Amortization
| 236.59 | 128.836 | 64.134 | 84.872 | 32.18 | 26.087 | 17.682 | 3.29 | 2.876 | 2.235 | 2.396 | 2.704 | 2.871 |
| Deferred Income Tax
| -46.93 | -34.276 | 0.377 | 5.872 | 8.829 | -0.49 | 0.199 | -0.199 | 2.303 | -19.31 | 0.092 | -1.783 | -0.462 |
| Stock Based Compensation
| 131.206 | 110.333 | 103.513 | 70.325 | 42.134 | 33.252 | 30.559 | 35.009 | 33.979 | 19.31 | 8.427 | 2.288 | 2.817 |
| Change In Working Capital
| -4.003 | -85.335 | -23.788 | 36.911 | 20.427 | 14.209 | 13.228 | -8.963 | 4.699 | 13.197 | -12.313 | -25.128 | -57.314 |
| Accounts Receivables
| -1.539 | -48.468 | -44.991 | -10.483 | 11.525 | -29.589 | -12.203 | -14.842 | -6.907 | -3.487 | 0.056 | 0.23 | 0 |
| Inventory
| -8.183 | -6.668 | 1.8 | 1.841 | -3.456 | -5.823 | -6.454 | 0.893 | -1.976 | -2.626 | 0 | 0 | 0 |
| Accounts Payables
| 48.346 | 27.542 | 23.413 | 53.585 | 13.746 | 43.107 | 24.011 | 4.259 | 16.981 | 16.914 | 5,183.412 | 0 | 0 |
| Other Working Capital
| -42.627 | -57.741 | -4.01 | -8.032 | -1.388 | 6.514 | 7.874 | 0.727 | -3.399 | 2.396 | -5,195.725 | -25.128 | -57.314 |
| Other Non Cash Items
| 151.323 | 82.805 | 128.333 | 46.109 | 49.367 | 27.382 | 7.269 | 9.407 | 2.253 | 21.047 | 6.049 | 0.226 | 0.417 |
| Operating Cash Flow
| -158.418 | -356.654 | -251.332 | -194.071 | -98.639 | -27.641 | -10.063 | -103.566 | -124.337 | -57.274 | -46.922 | -47.928 | -20.767 |
| Investing Activities: | |||||||||||||
| Investments In Property Plant And Equipment
| -120.619 | -152.46 | -85.331 | -55.977 | -45.439 | -15.53 | -3.101 | -1.776 | -2.72 | -4.664 | -0.846 | -0.189 | -0.165 |
| Acquisitions Net
| 86.063 | 128.436 | 57.118 | 38.134 | -4 | -48.892 | -77.163 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -212.484 | -75.551 | -543.266 | -1,449.665 | -494.068 | -68.614 | -81.368 | -85.377 | -223.762 | -247.804 | -156.045 | 0 | -2.019 |
| Sales Maturities Of Investments
| 156.366 | 518.192 | 847.779 | 944.094 | 156.27 | 90.423 | 174.749 | 191.634 | 205.671 | 107.3 | 29.062 | 0 | 29.887 |
| Other Investing Activites
| -86.063 | -128.436 | -57.118 | -38.134 | -373.48 | 13.376 | 16.218 | 106.257 | -18.091 | -140.504 | -126.983 | 0 | 0 |
| Investing Cash Flow
| -176.737 | 290.181 | 219.182 | -561.548 | -387.237 | -42.613 | 13.117 | 104.481 | -20.811 | -145.168 | -127.828 | -0.189 | 27.703 |
| Financing Activities: | |||||||||||||
| Debt Repayment
| -381.933 | -151.276 | -2.224 | -46.162 | -11.667 | 0 | -39.568 | 0 | -145.35 | -0.049 | -4.996 | -6.944 | -7.186 |
| Common Stock Issued
| 29.994 | 50 | 23.101 | 103.574 | 323.756 | 117.916 | 2.468 | 0.968 | 8.711 | 235.979 | 131.65 | 0 | 0.006 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 998.339 | 269.228 | 20.877 | 714.877 | 301.12 | 13.655 | 41.75 | 0.968 | 154.061 | 1.196 | 60.785 | 29.355 | 0 |
| Financing Cash Flow
| 646.4 | 167.952 | 20.877 | 668.715 | 613.209 | 131.571 | 44.218 | 0.968 | 154.061 | 237.126 | 187.439 | 22.411 | -7.18 |
| Other Information: | |||||||||||||
| Effect Of Forex Changes On Cash
| 3.114 | -2.772 | -7.821 | 7.688 | -1.303 | -3.611 | 6.199 | -1.584 | -0.639 | -0.35 | 0 | 0 | 0 |
| Net Change In Cash
| 314.167 | 98.707 | -19.094 | -79.216 | 126.03 | 57.706 | 53.471 | 0.299 | 8.274 | 34.334 | 12.689 | -25.706 | -0.243 |
| Cash At End Of Period
| 594.001 | 295.925 | 197.218 | 216.312 | 295.528 | 169.498 | 111.792 | 58.321 | 58.022 | 49.748 | 15.414 | 2.726 | 28.431 |